spacer

CDC HomeHIV/AIDS > Topics > Testing > Reports > HIV Prevalence Trends in Selected Populations in the United States

HIV Prevalence Trends in Selected Populations in the United States
space
arrow Cover
space
arrow List of Tables
space
arrow List of Figures
space
arrow Overview
space
arrow HIV Prevalence Among Selected Populations
space
arrow Interpretation and Discussion of Findings
space
arrow Appendix I
space
arrow Appendix II
space
arrow Appendix III
space
arrow Suggested Readings
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
 
Skip Nav spacer
Overview: Background
spacer
spacer

As part of a serosurveillance system to monitor the prevalence of human immunodeficiency virus type 1 (HIV-1) in the United States, the Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments, conducted standardized anonymous unlinked seroprevalence surveys in selected sentinel sites from 1988 through 1999. In addition, the Department of Labor, the Department of Defense, and the American Red Cross provide CDC with statistical data from routine HIV testing for surveillance purposes.

The objectives of the serosurveillance system are (1) to provide federal, state, and local health officials and the general public with standardized estimates of HIV prevalence among selected populations, (2) to describe the magnitude and changes over time of HIV infection in these populations within regions and within selected demographic and behavioral subgroups, (3) to recognize new or emerging patterns of HIV infection among specific subgroups of the U.S. population, and (4) to assist in directing resources and in targeting programs for HIV prevention and care.

From 1987 through 1999, CDC provided technical and financial assistance to state and local health departments to conduct anonymous unlinked HIV surveys in sentinel sites in selected metropolitan areas. The survey sites serve populations at high risk for HIV infection, such as those at sexually transmitted disease (STD) clinics and drug treatment centers (DTCs). Survey sites also included adolescent medicine clinics, which serve a population at lower risk. Investigators from state and local health departments chose clinics for participation in the surveys on the basis of client demographic and behavioral characteristics, local public health priorities, projected sample size, availability of voluntary counseling and testing, logistical considerations, and ability and willingness of the clinic staff to conduct surveys in accordance with national standardized protocols.

Anonymous unlinked surveys were used because they allow unbiased estimates of HIV infection among selected populations with increased HIV prevalence. Unlike surveys in which HIV prevalence rates are obtained through results that depend on client testing decisions, unlinked surveys are unbiased by self-selection because anonymous specimens from all clients are tested. Several steps were taken to ensure that these surveys were both anonymous and ethical: (1) only residual sera from blood specimens originally collected for routine diagnostic purposes were used in the surveys; (2) before specimens were tested for HIV, all personal identifying information was permanently removed to ensure that neither HIV test results nor survey information could be linked to specific individuals; (3) no interaction with survey participants could take place solely for the purpose of the surveys; thus, the integrity of the studies was in no way compromised and each person’s right to privacy was protected; and (4) all clinic sites that conducted unlinked surveys offered voluntary HIV counseling and testing allowing anyone visiting a site the opportunity to learn his or her HIV status and to receive appropriate counseling and referral services.

CDC also monitors HIV prevalence in three populations in which HIV screening is routinely performed. Since 1985, the American Red Cross has provided CDC with HIV test results for blood donors. In addition, the U.S. Department of Defense has provided HIV test results for applicants to the military service since 1985. Beginning in 1987, the U.S. Department of Labor has provided HIV test results for entrants to the Job Corps, a federally funded job training program for disadvantaged youth. As is true of all the unlinked surveys, personal identifiers for participants in these screening programs are not available to CDC.

Results from routine HIV screening of Job Corps entrants, military applicants, and blood donors provide important additional information on the evolving HIV epidemic. Although geographically diverse, each of these groups is disproportionately composed of persons with particular demographic and socioeconomic characteristics. Job Corps entrants comprise young men and women who are educationally or economically disadvantaged. Military applicants and blood donors are low-risk populations because persons with known HIV infection are not accepted into the military and potential blood donors with known HIV infection or risk factors for HIV infection are likely to have self-deferred.

This report complements three previous CDC prevalence reports: (1) National HIV Prevalence Surveys, 1997 Summary; (2) National HIV Serosurveillance Summary, Update–Results through 1993; and (3) National HIV Serosurveillance Summary, Results through 1992. Because fewer clinics were funded by CDC to conduct unlinked surveys from 1993 through 1997 than in earlier years, the number of clinics represented in this report is substantially lower than the number in previous CDC reports. For example, in the earlier CDC report of HIV trends (National HIV Serosurveillance Summary, Results through 1992), data were analyzed from 112 STD clinics in 46 cities, 78 DTCs in 35 cities, and 21 adolescent medicine clinics in 12 cities. This report presents data from 23 STD clinics in 13 cities, 22 DTCs in 14 cities, and 5 adolescent medicine clinics in 3 cities.

Included in this report are summaries of data from January 1993 through December 1997 from the unlinked prevalence surveys1 conducted in selected STD clinics, DTCs, and adolescent medicine clinics, as well as data from routine HIV screening programs for entrants to the Job Corps, applicants for military service, and first-time blood donors. High-risk populations include men who have sex with men (MSM) and heterosexual patients at STD clinics and injection drug users (IDUs) entering DTCs. Youth populations include patients at adolescent medicine clinics and Job Corps entrants. Low-risk populations include military applicants and blood donors (Table 1).

Go to Collection and Analysis of Data


1. The unlinked prevalence surveys were discontinued at the end of 1999. Because of the small number of participating clinics in 1998 and 1999, this report includes only data through 1997.
spacer
Last Modified: May 22, 2007
Last Reviewed: May 22, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services